Cal. Code Regs. tit. 16, § 1737.1
In addition to the requirements in USP Chapter 800, the following requirements of this article apply to the compounding of Hazardous Drugs that is performed by or through a licensee of the Board.
In addition to the provisions in section 1707.2, consultation includes handling and disposal of a compounded HD or related supplies furnished. A pharmacist is not required by this subsection to provide oral consultation to an inpatient of a health care facility licensed pursuant to section 1250 of the Health and Safety Code, or to an inmate of an adult correctional facility or a juvenile detention facility, except upon the patient's discharge. A pharmacist is not obligated to consult about discharge medications if a health facility licensed pursuant to subdivision (a) or (b) of Health and Safety Code Section 1250 has implemented a written policy about discharge compounded medications which meets the requirements of Business and Professions Code Section 4074.
Note: Authority cited: Sections 4005, 4126.8 and 4127, Business and Professions Code. Reference: Sections 4005 and 4126.8, Business and Professions Code.
1. New section filed 6-19-2025; operative 10-1-2025 (Register 2025, No. 25).